Univar to acquire Eral-Protek
The acquisition, along with the Istanbul and Izmir operations of Basic Chemical Solutions, whose global business was acquired by Univar, will immediately give Univar a strong local presence
Innovent Biologics and Daiichi Sankyo have signed an exclusive agreement to commercialise Vanflyta (quizartinib), an oral type II FLT3 inhibitor, in China.